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Abstract
Bioactive glasses are very attractive materials, used for tissue engineering  
materials, usually to fill and restore bone defects. This category of biomaterials, 
show considerable potential for orthopaedic surgery because they can promote 
bone tissue regeneration. Many trace elements have been incorporated in the glass 
network, an example is metallic glasses to obtain the desired properties. Because of 
tolerable mechanical properties, and because they are able to bond to living bone and 
stimulate its regeneration, this bioactive glasses have a particular interest and are in a 
continuous research and improvement. The chapter presents the history of bioactive 
glasses, classification, include a summary of common fabrication methods, applica-
tions, surface coatings, applications and future trends in relation to human bone. 
This review highlight new trends and areas of future research for bioactive glasses.
Keywords: bioactive glasses, bioactivity, glass-ceramics, biodegradable,  
melt-derived glasses, bone, applications, tissue engineering
1. Introduction
Research in the field of materials science and engineering has expanded greatly 
in recent decades, especially in the field of biocompatible materials. This is because, 
on the one hand, medicine is constantly looking for solutions to remedy many 
health problems, and on the other hand, certain classes of materials have already 
proven useful in alleviating or even curing certain human suffering [1, 2].
The development of biocompatible materials research is an evolving process 
driven by the increase in the number of accidents and many health problems, but also 
by the desire to increase the average life expectancy in humans. As research in the 
field of biomaterials science advances at the laboratory level, the incidence of serious 
diseases is increasing in the global human community. The World population is get-
ting larger and the percent of elder persons is increasing and influencing the increase 
of chronic illness, like cancer or cardiovascular diseases. Next to this on large scale 
other infectious diseases are getting more common like: HIV/AIDS, tuberculosis or 
gastrointestinal issues. On this reason the focus of the research in the field of medical 
materials and instruments should prepare for the request on the market [3].
While traditional biomaterials were based on polymers, ceramics and metals, now 
the latest generation of biomaterials incorporates biomolecules, therapeutic drugs 
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and even living cells. At present, biomaterials are a special category of materials, 
indispensable for raising the quality of human life and extending its duration [4].
Biomaterials are generally intended to be implanted in a living organism to 
restore the shape and function of a part of a tissue destroyed by disease or trauma.
The introduction of a biomaterial into the human body determines an implant 
versus tissue interaction, which can generate conflicting reactions. They can be 
toxic, mechanical, and electrochemical biological. It can even lead to serious 
damage to the bone or adjacent tissue, or assembly used. Due to these phenomena, 
depending on the quality of the biomaterial, the place of implantation and other 
causes, corrosion occurs on the surface of the implant, with loss of quality his.
Depending on the medical application for which it is suitable, a biomaterial must 
have one or more of the properties presented in Figure 1. These factors are very 
important and have a close correlation between them: to be biologically compatible 
with the host tissue (for example, it does not have to causes rejection, inflammation 
and immune responses); Easily achieve direct bio-chemical attachment to the host 
tissue; The biodegradation time must be adjusted to suit the time of natural bone 
formation; Degradation mode: Surface or depth erosion; Ability to support the 
growth of germinal capillaries, tissues perivascular mesenchymal and osteopro-
genitor cells from host in the three-dimensional structure of the graft that acts as a 
support; Needed to maximize space for grip and growth cellular, revascularization, 
proper nutrition and oxygen supply; For support in the process of cell growth and 
in the transport of nutrients and oxygen [5].
A material suitable for use in medicine must have, where appropriate, certain 
characteristics special and offer a number of advantages: mechanical integrity of the 
tissues acting as a support for growth living tissue; control of the biological response, 
by promoting dynamic interactions with tissues surrounding; behaving as a space for 
the survival of host cells, facilitating the transport of nutrients and metabolites, by 
maximizing the biological and / or pharmaceutical response; good biocompatibility /  
biodegradability, with adequate degradation kinetics; new tissue formation, thus 
minimizing both tissue and response toxicity systemic; feasibility in production [6, 7].
Of all the factors, biocompatibility is the most important feature to be taken 
into account consideration in the clinical applications of a biomaterial and which is 
related to behavior biomaterials in various contexts. Biocompatibility is correlated 
with the appearance of a response weak immune system in contact with a particular 
biomaterial [8, 9].
The most complex unit is the human body, having many levels of tissues, organs 
and systems. If we speak about tissues these can be soft or hard, after that being classi-
fied in ones in contact with blood or not, in contact with the biomaterials or not [10].
Figure 1. 
The main characteristics of biomaterials.
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On biomaterials the classification can vary, according to the composing materi-
als and their use; the origin – natural or synthetic, simple or mixed composite 
and so on. Regarding the composition these can be metallic, ceramic, polymeric, 
composite and of natural origin.
According to every biomaterial, the advantages and disadvantages can influence 
their use, being induced by the characteristics of biomaterials and by the functional 
requirements of implants.
Bioglass (BGs) is a chemical compound that is part of a compositional fam-
ily known to have the best bioactivity properties. This are osteoconductive and 
osteoinductive as well biocompatible and highly bioactive, as demonstrated by the 
connection with living tissues in a short time to just a few hours [11].
This new class of biomaterials, based on an amorphous mixture of oxides 
(SiO2-Na2O-K2O-CaOMgO-P2O5), was patented in 1968 by Larry Hench by 
preparing the well-known Bioglass 45S5.
Depending on the percentage of SiO2 mainly, these biomaterials can be bioinert, 
bioactive or bioresorbable. Hench and Clark were the first researchers to observe 
the bioactivity of this material in vitro and in vivo and demonstrated its osteointe-
grative potential [12].
At the same time, the antimicrobial and anti-inflammatory properties and 
the possibility to easily control the crystallinity by applying heat treatments cor-
responding to the glassy phase present in the bioglass structure were noted. All 
these are additional arguments for this class of biomaterials to be a first objective in 
research in the field [13].
L.L. Hench developed the concept of using a material based on silicon dioxide, 
calcium oxide and phosphorus pentoxide, in a proportion similar to that of natural 
bone, to make implants, which have the property of developing a bond with the 
bone. In Figure 2 is presented the Hench Diagram. The level of biocompatibility of 
a material can be correlated with the time in which it was performed bone binding 
for more than 50% of implant surface (t0.5bb) [15].










Hench diagram [14]. *notations: A - bioactive materials, B - inert materials, C - absorbable materials,  
D - cannot be obtain bioglasses, la = 0 the limit of the compositions that allow the binding to the hard tissues, 
la = 8 is the limit of the compositions that allow the binding of soft tissues.
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Year Stage/Achievement/Application
1969 Highlighting the binding (binding) of the bone with the help of bioglass and bioglass-ceramics
1973 Specification of the interaction mechanism at the bone-bioglass interface
1973 Binding of bone to active biovitroceram
1976 Measurement of the profiles of compositions in the bioglass-bone connection area
1976 Successful introduction of bioglass into the dental implant
1980 Comparative histology of variable bioactivity implants
1981 Ultrastructure analysis of biovitroceram and bone
1981 Toxicology and biocompatibility tests of biostycles and evidence of soft tissue binding
1981 Clinical use of vitroceram (Ceravital) in the middle ear prosthesis
1982 Comparison between the glass implant and other inert implants instead of the middle ear bone
1982 High mechanical strength vitroceram (apatite and wollastonite) for vertebral prostheses
1983 Mechanically machinable vitroceram based on apatite and fluoroflogopite
1984 The FDA approves the sale of bioglasses and prostheses for the middle ear
1986 Clinical trial of bioglasses for alveolar ridges
1993 PerioGlas approved by FDA (45S5 Bioglass® for bone and dental repair)
1998 Peripheral nerve repair
1999 Radioactive glasses approved by FDA (TheraSphere®) for cancer treatment
2000 Wound healing
2002 Medpor®-PlusTM approved by FDA (polyethylene/45S5 Bioglass® composite porous orbital 
implants).
2003 Antibacterial (Zn-containing) bone/dental cements
2004 Lung tissue engineering
2004 Use of mesoporous bioactive glass (MBG) as a drug delivery system
2005 Skeletal muscle and ligament repair
2005 Treatment of gastrointestinal ulcers
2010 Cardiac tissue engineering
2011 Commercialization of a cotton-candy borate bioactive glass for wound healing in veterinarian 
medicine. FDA approval was pending.
2012 Embolization of uterine fibroids
2012 Spinal cord repair
2018 Use of radioactive glasses (TheraSphere®) in patients with metastatic colorectal carcinoma of 
the liver
Table 1. 
Stages of development of bioglass and glass-ceramics [4, 5, 15].
Because some studies show that the GBs are fragile and exhibit poor mechanical 
properties, this limiting the involvement in load-bearing applications, another way 
to represent a feasible solution, is to incorporate the bioactive glasses into gelatine 
matrices and to fabricate composites [16, 17].
2. History - current level of development
Although 40 years have passed since the patenting of this material, until now it 
has been intensively used only in the form of large diameter particles (~ 100 μm), 
grouped in blocks with different geometries, with applications in regenerative 
orthopedic surgery (bone fillers).
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Enamel-glazing and flame / plasma spray are used as commercial methods to 
obtain bioglass thin films at the commercial level, and in recent years’ intensive 
research has been carried out in many biomaterials research laboratories to find 
alternative methods to the traditional ones, which lead to thick coatings with low 
mechanical strength.
Although their superficial properties are interesting, their development is 
limited due to: high fragility and reduced mechanical resistance to static fatigue. 
However, they are used to make middle ear bones, alveolar reconstructions, dental 
implants, films for total coverage of prostheses (alumina or titanium alloy), for 
modern cancer treatments.
For all these applications, the bioglasess have seen a spectacular development, as 
shown in Table 1.
Due to the high fragility and low mechanical strength of bioglasses as well as the 
toxicity of metal ions that can occur from metal alloys used in internal prostheses, the 
study of metal orthopedic prostheses coated with thin bioglasses films was studied.
Their use is motivated, among other things, by the porosity characteristics of 
the bioglasses, which allow a very intimate propagation of the tissues, thus ensuring 
a perfect connection with the implant. Thus, these structures have the advantage 
of combining the bioactive properties of the coating material with the mechanical 
strength of the support (Figure 3).
Bioglasses are superficially active, they have the property of binding mechanically 
or biochemically to bone tissue or collagen fibers in contact with soft, living tissue.
It has been shown that the connection between the bioglass and the bone is 
achieved by the formation of a superficially active interface based on hydroxyapa-
tite, which further determines the reconstruction action of the tissue cells; such a 
mechanism is stimulated by a slightly basic pH, caused by ion exchanges between 
the bioglass and the tissue.
Materials with limited reactivity, such as dense hydroxyapatite, have a weaker 
effect than biosticles in the healing process of bone tissue.
All classes of the biomaterials are used throughout the human body, for this 
purpose, physical, chemical and biological properties of materials are exploited, 
often new or improved properties, and the resulting structures can interact faster at 
the biomolecular level, both on the surface and inside the cell.
3. Relevant studies
Most of the commercial biomaterials (glass, ceramics, glass-ceramics and com-
posites) are known that bind to bones, being called bioactive ceramics. Also other 
strictly specialized compositions of bioactive glasses bind to soft tissues. A common 
feature of bioactive glasses and ceramics is the change of the material surface after 
Figure 3. 
Multilayer structure [9].
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time-dependent implantation. On the surface it is formed a biologically active layer 
of hydroxycarbonate apatite (HCA), which provides the tissue-binding structure [4].
Many studies have shown bone-related bioactive implants with sufficient adhe-
sion to the interface to withstand mechanical fracture. A failure never occurs at the 
interface, but either in the implant or in the bone.
Bone binding was initially demonstrated for some compositional domains of 
bioactive glasses, containing SiO2, Na2O, CaO and P2O5, in the proportions specified 
in Table 2.
During the years many types and variations of the composition were approved 
by FDA and named Bioglass.
When introducing a material into the living organism, a series of very complex 
interactions can appear, being able to identify four specific phenomena that are 
unitary in the so-called “concept of biocompatibility”, namely:
1. initial processes that take place at the biomaterial interface ÷ living tissue 
and that are closely related to the physico - chemical processes that take 
place in the first minutes of the contact between the biomaterial and the 
living tissue;
2. the effect induced by presence of biomaterial as a foreign body in the living 
tissue surrounding the implant, which can be measured at any time, from a 
few minutes to years;
3. the effect that living tissue has on the biomaterial through the changes observed 
in the biomaterial, effect described in the form of corrosion or degradation;
4. consequences of the reaction at the interface that are systematically seen on 
the surface of the body or in certain specific areas, medically recognized as the 
development of specific allergies, the initiation of tumors or the appearance of 
infectious processes [5].
Chemical interactions that occur at the surface are:
• Rapid exchange of Na + and Ca2 + ions with H + and HO- ions in solution, 
leading to hydrolysis of silica groups, with the formation of silanol groups;
 O HSi Na HO Si OH Na HO+ + - + -- - + + ® - + +  (2)
• The cation exchange increases the concentration of hydroxyl ions in the solu-
tion, which leads to the attack of the silica network;
• Condensation and repolymerization of a SiO2-rich layer on the glass surface, 
depleted in alkaline and alkaline-earth cations;
• Migration of Ca2 + and PO4
3− cations to the surface through the SiO2-rich 
layer, forming above it an amorphous CaO-P2O5-rich film, which grows by 
incorporating calcium and phosphates from the solution;
• Crystallization of the amorphous film rich in CaO-P2O5 by incorporation from 
the solution of OH- and CO3
2− anions, with the formation of a mixed layer 


















































SiO2 45 45 30 52 55 46.2 46 38 34.2 19–52 45
P2O2 6 6 6 6 6 16.3 4–24 7
CaO 24.5 14.7 24.5 21 19.5 20.2 33 31 44.9 9–3 22
Ca(PO3)2 25.5 16 13.5
CaF2 9.8 0.5
MgO 2.9 4.6 5–15
MgF2
























Composition of bioactive glass and glass ceramics (% weight) [18].
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The biomaterial versus tissue interface, which is established by implantation, is 
almost inevitably a blood ÷ material interface and the initial events are dominated 
by the absorption of blood proteins on the implant surface. At this contact it was 
established that a series of biological processes: Adsorption and desorption of 
biological growth factors, in the HCA layer, which determines the activation of 
stem cell differentiation; The action of macrophages, which phagocytose local 
residues, allowing cells to grow; Attachment to the bioactive surface of stem 
cells; Differentiation of stem cells with the formation of bone growth cells, called 
osteoblasts; Osteoblasts generates extracellular matrix with bone formation; 
Crystallization of the phosphate inorganic matrix by embedding bone cells in a 
living composite structure (Figure 4) [19].
The chemical and topological properties of the implant surface strongly influ-
ence the properties of the biolayer and this influence must be understood and 
controlled in order to optimize the biocompatibility of the material used. Relevant 
in the study of biocompatibility is the fact that proteins and cells have nano- and 
micrometer sizes, which requires extremely delicate approaches. Of equal impor-
tance are the properties of cells, for example, their ability to communicate via the 
extracellular matrix with signal molecules (molecules used in the process of living 
cell synthesis). During tissue healing, numerous bioactive signaling molecules con-
trol tissue formation, and some proteins have demonstrated the ability to stimulate 
healing near the implant. All these mechanisms contribute to the response of the 
tissues to the implant and can determine whether the body accepts the implant or 
not, whether it is biocompatible.
Japanese researchers have tested the effect of surface area on bone proliferation. 
Three types of biomaterials were compared: bioactive glass, dense hydroxyapatite 
and glass ceramics. Each material was implanted in a 6 mm diameter hole, which 
was drilled into the bone of an adult rabbit’s leg. Bioactive glass has been found to 
produce bone tissue and is subsequently resorbed much faster than the other two 
materials, both of which have a lower surface reactivity than glass.
The rate of bone growth around an implanted material depends in part on the 
rate of dissolution of the silica network and therefore it is very good to determine as 
accurately as possible the system in which the oxide composition of the bioglass.
Alkaline content plays an important role in the stability of bioglass. From this 
point of view, two categories are distinguished: bioglass with rich alkaline content 
and bioglass with poor alkaline content. The latter are characterized by a high degree 
of decomposition over time, during bone reconstruction. This type of bioglass has 
been used in maxillofacial applications and in the chaining of the inner ear bones.
Figure 4. 
Bioactive glass surface reaction [19, 20].
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Most determinations were made with glasses based on 6 oxides: SiO2-Na2O-
K2OCaO-MgO-P2O5, as it was found that the bone binds to materials with a wide 
range of compositions in this system. Soft tissue binding occurs for a much smaller 
range of compositions.
There are three basic compositional requirements for silico-chalco-sodium 
glasses to bind to hard tissue. These are: less than 60% SiO2 (mol), high content of 
Na2O and CaO, high CaO / P2O5 ratio. The level of bioactivity is strongly dependent 
on the relative concentrations of ions.
The most successful bioactive glass is the one that contains P2O5 between 6 
and 15%.
In the diagram of the SiO2-CaO-Na2O ternary system (6% P2O5), some materials 
form a bond with the bone in 30 days. Other glasses bind to the soft tissue, some of 
the glasses are almost chemically inert and others are resorbable and dissolve in 10 
to 30 days.
Bioglasses from another part of diagrams, from a technological point of 
view, are not forming glass and have not been tested as implant materials. Until 
now, it has been considered that in order to be bioactive, glasses and glass-
ceramics must contain both CaO and P2O5, which are the component oxides of 
hydroxyapatite.
Ohura and collaborators have shown that glasses in the CaO-SiO2 system with-
out P2O5, as well as those containing very small amounts of P2O5, form a layer of 
hydroxyapatite on their surface when immersed in simulated body fluid (SBF). In 
contrast, under the same conditions, the glasses in the SiO2-free CaO-P2O5 system 
do not form the hydroxyapatite layer. It follows that bioactive compositions can be 
obtained in the CaO-SiO2 system rather than in the CaO-P2O5 system.
Bioactive glasses usually have weak strength and resilience properties, which 
is why they are reinforced with metal fibers made of stainless steel, titanium and 
Co-Cr alloys. As a result of the reinforcement with metal fibers, the volume of 
defects and the residual tensions decrease, and the microcracks produced are below 
the critical length and have rounded extremities.
4. Methods of obtaining
The most methods used for bioglass nanoparticles obtain are: quenching 
method, sol–gel, flame synthesis, microwave irradiation and microemulsion. Two 
main process that can synthesize the biomaterial are the melt quenching method 
and sol–gel.
4.1 Quenching method
The melt queching method can synthesize bioglass in a short time, by heat-
ing the initial precursors to high temperatures and following special rules. The 
preparation process proposed by Hench by melting is based on the following steps:
• Melting of the mixture of high purity raw materials, in Pt-10% Rh crucibles, 
covered, in order to prevent the volatilization of the components.
• The melt is loosened for at least 2 hours, without removing the lid.
• The glass is poured into graphite molds. If the sample diameter is larger than 
1 cm then the mold is preheated to 300°C.
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• The glass is annealed at different temperatures depending on the composition, 
for 4 hours (see Table 3)
• The glass is cooled slowly in the oven for 16 hours.
The role of annealing is to create the conditions for the formation of microcrys-
tals, thus obtaining a bioactive glass–ceramic.
The melt quenching method synthesis was also carried out by Shams et al. in 
2018. Bioglass nanoparticles were prepared from analytical grade SiO2, Na2CO3, 
CaCO3, and P2O5 precursors. As an example from the literature [21]: the precursors 
were mixed in 53.0 SiO2:23.0 Na2CO3:20.0 CaCO3:4.0 P2O5 molar ratios followed by 
milling in an agate mortar [22]. The blend was mixed in a jar for several hours and 
then pressed into discs with 10 mm in diameter using a hydraulic press apparatus. 
Than the samples were placed in an alumina crucible and heat treated in the fur-
nace [21].
In Figure 5 we can see the thermal program: melting at 1400°C for 3 hours - 
resulting molten material, then quenched in distilled water to produce glass frit. 
The glass frit was than dried in an oven at 80°C for 5 hours. The dried glass frit was 
milled in a Retch PM400 milling machine using zirconia cups for 6 h to obtain the 
bioglass powder [21]. FESEM micrograph of bioglass nanoparticles, includes spheri-
cal particles with a wide size distribution from 100 to 800 nm [21].
Although the melt technique is a fast method, the resulting glass usually has a 
low specific surface area value. According to previous research, the specific surface 
area value is a key factor affecting bioglass bioactivity. Increasing the specific 
surface area can increase the surface reaction between the artificial material and the 
physiological environment, thereby increasing the formation of the HA layer.
4.2 Sol–gel method
One of the most common method - the sol–gel process is well known for 
obtaining synthetic materials, like silicate and oxide systems and respectively 
thin films, coatings, nanoparticles, and fibers. The sol–gel reactions takes 
place at low temperatures and involves the synthesis of a solution (sol), usually 
consisting of metal–organic and/or metal salt precursors followed by gelling by 
chemical reactions, or aggregation, and finally thermal treatment for drying, 
removal of organic substances, and sometimes crystallization and cooling. Some 
ions (magnesium, zirconium, zinc, silver, titanium, boron) can be also added 
to the bioactive glass in order to enhance glass functionality and bioactivity. 
However, bioactive glass is difficult to synthesize on a nanoscale with the  
addition of ions [22].
The sol–gel method can synthesize bioglass at lower temperatures, has a porous 
structure, and a high specific surface area value which can increase the bioactivity 
of synthetic materials.
The raw materials used in the sol–gel method are alkoxide precursors or soluble 
inorganic salts derived from the oxide components of the glasses.
Type 45S5 45B15S5 KLP1 KZS3020 45S5N 45S5-L 45S5-F
Tmelting [°C] 1350 1150 1350 1500 1350 1350 1200
T annealing [°C] 500 375 550 700 550 550 350
Table 3. 
Heat treatment temperatures for Hench glasses.
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If a glass is prepared in the SiO2-CaO-P2O5 ternary system, the precursors 
used may be:
• TEOS - tetraethylorthosilicate (C8H20O4Si)
• Calcium nitrate (Ca (NO3)2 ∙ 4H2O)
• PET - triethylphosphate (C6H15O4P)
The following factors are considered: the raw materials are added dropwise, under 
continuous stirring; the pH is adjusted with nitric acid to 2–3 thus taking place an 
acid catalysis; the soil thus obtained is left to gel for a few hours in an oven at 60° C.
The advantages of the sol–gel method are:
• Low obtaining temperature;
• High purity;
• Improved homogeneity;
• Variation of the composition in order to maintain bioactivity;
• Modification of structural characteristics, by controlling hydrolysis and 
condensation reactions;
• Powders of nanometric dimensions;
• Nanostratified porous materials.
Kumar et al. [23] synthesizing bioglass nanoparticles (SiO2 (60%)-CaO  
(30%) -P2O5 (10%)) through the sol–gel method. The synthesis of bioglass 
nanoparticles was carried out by mixing TEOS (4.054 g) with ethanol using a 
magnetic stirrer for one hour at room temperature. In separate containers, calcium 
nitrate tetrahydrate (2.372 g) and phosphate pentoxide (0.267 g) were dissolved 
in distilled water and stirred each with a magnetic stirrer for 30 minutes at room 
temperature as well. After one hour, the solution containing calcium was added 
dropwise to the solution containing TEOS, as well as the solution containing the 
phosphate. After that, ammonia solution was added to the mixture to maintain 
pH 11. The mixture was then put in an incubator for 48 hours to obtain the gel. The 
obtained gel was placed in an oven at 100°C to dry [23]. The result of TEM analysis 
shows that the shape of the bioglass nanoparticles is irregular at the nano and micro 
Figure 5. 
The furnace temperature programming. Image adopted from [21].
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Composition Form Application Function
Bioglass 45S5 Solid 
body
Reconstruction of the 
alveolar margin
Filling the space and tying the tissue
Solid 
body
Middle ear prosthesis Reconstruction of the ear canal by 
replacing part of the bone chain
Powder Reconstruction of defects 
caused by periodontitis
Replacing lost bone and preventing gum 
retraction
Powder Fixation of hip implants Replacement of lost bone due to a 
defective fixed implant
Table 4. 
Applications for BIOGLASS 45S5.
scales due to the presence of agglomeration, the particle size varies from 200 to 
500 nm, average surface area of the bioglass nanoparticles measured using BET 
with N2 was 10.4 m2/g. The larger the particle size, the smaller the surface area.
Another study made by Durgalakshmi et al., by mixing tertraethyl ortho-
silicate (TEOS) and HNO3 as an acid medium, then added alcohol to help the 
hydrolysis process. Gel formation occurred after 30 minutes of mixing. At 
20 minute intervals, other reagents are added to the mixture such as phosphoric 
acid, calcium nitrate, and sodium hydroxide. The solution was mixed for 4 hours 
to obtain a homogeneous gel. After the hydrolysis process is complete, the sol is 
stored at 70°C for 24 hours, and then the dry white powder is taken at 600°C for 
2 hours [24]. Scanning electron microscope analysis shows that the particles do 
not have a well-defined shape, having less than 100 nm in length [24]. The large 
particles of over 200 nm could be formed due to particle agglomeration during 
sintering [25].
5. Applications
From ancient times there has been an interest in repairing and replacing parts 
of the human body that present problems and this has been done using various 
materials more or less suitable depending on the information available at that 
time [26].
Due to the evolution of science and equipment today, the medical world is in a 
period of transition from the healing of existing organs to their replacement with 
synthetic materials obtained in high-performance laboratories [27].
Bone replacement is in the 2nd place as a tissue replacement procedure, in the 
first place being the blood transfusion. Yearly are done more than 2 million bone 
reconstructions in orthopedics, neurosurgery and dentistry.
A wide variety of biomaterials are used in restorative medicine. The choice of 
material for a practical application in medicine remains a key factor in the design 
and development of medical implants and devices. Currently, more than 50 bio-
materials (BIOGLASS 45S5®, CERABONE A-W®, TheraSphere®, Corglaes®, 
NovaBone®, NovaMin® etc.) of synthetic or natural origin are used in medicine, 
covering a wide variety of applications. The tables below (Tables 4 and 5) show 
some of the applications of bioactive glass and glass ceramics due to their well-
defined bioactive properties [28].
Figure 6 illustrate some examples of commercially glasses, available on the 
market. All research leads to a great potential of BGs in medicine but it is not fully 
exploited yet and the next years a rapid growth is expected.
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6. Future trends
It is hard to say which is the most feasible bioglass. So the focus of the research is 
now on optimisation of the materials with deposition techniques, influenced by the 
parameters of the coatings and the composition of the bioglass, in order to obtain a 
multi-functional coatings, that will give long-term qualitative implants without side 
effects and ensuring regeneration.
Figure 7 shows the challenges and future trends for bioactive glasses (BGs)in 
medicine promoted by researchers which will lead to better implants. The proper-
ties of a biomaterial are decisive in ensuring the biocompatibility of an implant:
• from a chemical (compositional) point of view, a biomaterial must not contain 
elements that generate adverse and / or inflammatory reactions upon implan-
tation. An important aspect is also related to the possible formation on the 
implant surface, in in vivo conditions, of new structures and compositions, 
dependent on the interactions that are manifested between the biomaterial and 
Composition Form Application Function
Cerabone A-W 
glass–ceramic
Solid body Iliacal ridge 
prosthesis




Replacement of a vertebra lost during 
surgical removal of a tumor
Deposition Fixing hip 
prostheses
Provides bioactive binding of the implant
Table 5. 
Applications for CERABONE A-W.
Figure 6. 
Examples of commercially produced glasses, available on the market [29–33].
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Figure 7. 
Challenges and future trends for bioactive glasses (BGs)in medicine [34].
the environmental conditions specific to the implantation area. Their nature 
and physico - chemical characteristics can affects the long-term reliability of 
the implant.
• from a structural point of view, a biomaterial must have a density and a poros-
ity corresponding to the structural function that the implant is to fulfill in the 
organism in which the implantation is made. Of particular importance is the 
microscopic nature of the implant surface.
• mechanical properties - a biomaterial, depending on the function that the 
implant must perform in the living organism, must have adequate mechanical 
strength, hardness and reliability.
• in the case of ocular, dermatological and dental applications, biomaterials must 
also have appropriate optical properties.
• another important aspect is related to the machinability of the biomaterial, this 
influencing the engineering of the implant itself.
Reliable Coatings with BGs on the mettalic implants are the oldest challenge 
but still researched. Thanks to their excellent mechanical properties and corrosion 
resistance, some metals are used as passive substitutes for the replacement of hard 
tissues (total hip and knee implants), as well as fracture implants (plates and rods), 
column fixing devices, and implantology. Dental. Other metal alloys have more 
active roles in implantology, such as vascular stents, catheter guidewires, orthodon-
tic wires, and cochlear implants.
However, the biocompatibility of metal implants creates considerable concerns 
due to the fact that they can corrode in an in vivo environment [6]. Weakening of 
the implant by disintegrating its actual material, respectively the harmful effects of 
the resulting chemical compounds on neighboring tissues and organs are among the 
consequences of corrosion.
Pure metals are less commonly used, their alloys being used more often due to 
the fact that they improve some of their properties, such as corrosion resistance and 
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hardness. Three groups of materials dominate the group of metallic biomaterials: 
316 L stainless steels, cobalt and pure titanium alloys or titanium alloys.
Every material and class of materials works differently after the implantation, 
like some metals encapsulate fibrous tissue. The great advantage of the coatings on 
bioglass is that is not releasing toxic ions in the human body due to the potential to 
improve the implant stability by bonding it to the host bone and protect the implant 
from corrosion resistance.
The technologies involved for the surface modification of metallic implants with 
bioglass are: thermal spraying, sol–gel, chemical and electrochemical treatment. 
Unfortunately, not all technologies are suitable, some of them show many disad-
vantages like poor bonding strength between implants and coatings, the induction 
of phase transformation, modifications in the properties of coating or metallic 
implant, or both, and presence of impurities. Table 6 present a synthesis of differ-
ent glass coatings obtained through various methods [57].
Another perspective and future tendince of biomaterials is nanomedicine. 
Nanomedicine can be defined as an application of nanotechnology in the field of 
health in order to maintain and / or improve the health of the population using 
knowledge about the human body at the molecular level, as well as tools / nanoscale 
structures [22].
For this purpose, physical, chemical and biological properties of nanoscale 
materials are exploited, often new or improved properties, and the resulting 
nanostructures (nanoparticles or nanodevices), having the same size as biological 
entities, can interact more rapidly at the biomolecular level. on the surface as well as 
inside the cell [22].
So, in the near future, nanomedicine will seek to provide the tools and devices 
for research and practice, useful in the medical clinic, which could revolutionize the 
current way of thinking (prevention and diagnosis) and action (applied therapies) 
in the medical field.
By using nanoengineering, artificial tissues can be obtained and used to replace 
affected organs (kidneys, liver) or to regenerate nerves or produce implants that 
restore lost senses, such as sight or hearing. A major contribution is expected to 
nanomedicine could be brought about in areas such as: the definition and clas-
sification of diseases, their diagnosis and treatment, and the improvement of the 
structure and functioning of the human body [22].
In recent years, nanotechnology has found countless applications in the medi-
cal field, in the fields of: pharmaceutical (in targeted drug therapy), regenerative 
medicine (making nano-robots and devices used in cell regeneration), disease 
prevention, diagnosis (including by methods high-performance imaging) and 
nano-technology-based therapy.
The future of the field stays in the nanotechnology, being the most effective on 
cell and tissue level, mainly on the integration and regeneration, but also the identi-
fication of effective ways to trigger and control the regenerative process. The “nano-
biomimetic” strategy depends on the following elements: intelligent biomaterials, 
bioactive signaling molecules and cells. Biomaterials are designed to react positively 
to changes in the proximity environment, stimulating specific regenerative events 
at the molecular level, directing cell proliferation and then differentiation, as well as 
the production and organization of the extracellular matrix.
A huge impact will also have the ability to implant cells, intelligent bioactive 
materials, which trigger the process of self-healing through the patient’s own stem 
cells [22].
The field of nanotechnologies has established itself in recent years as one of the 
most topical fields, with a sustained pace of development and application and a 
revolutionary impact on industry and society. The global emergence of government 




Substrate Technique Coatings’ characteristics Ref.
Biovetro® Ti6Al4V Atmospheric plasma
spraying (APS)
Surface with wide superficial 





APS Bonding strength of BG + bond 
coat average 27.18 ± 2.24 MPa, 
and of BG average 
8.56 ± 0.57 MPa.
[36]
P1, P2 AISI 316 L APS Microhardness of the coating 
4.7–5.2 GPa; thickness 
of M1 389.8 ± 5.4 μm, 
M2 91.2 ± 8.2 μm, M3 
262.6 ± 5.4 μm,
and M4 80.8 ± 6.5 μm; adhesion 
strength of M1 2.7 ± 0.5 MPa, 




P0, P2 AISI 316 L
& Ti6Al4V
Flame spraying (FS) Microstructure consists of 
melted particles, pores and both 
vertical and parallel cracks. 
Thickness 126–275 μm;
fracture toughness 5–7 MPa/
m1/2; Vickers hardness 4–5 HV
[38]
45S5 AISI 304 Solution precursor
plasma spraying
(SPPS)
Uniform coating average 
thickness 35 μm
[39]
Bio-K Titanium High velocity
suspension flame
spraying HVSFS
Coatings are entirely glassy. 
Tensile adhesion strength 
without bond coat:
BioK-1 7 N/mm2, BioK-2 3.8 N/
mm2, BioK-3 5 N/mm2, BioK-4 
9.8 N/mm2 BioK-5 8 N/mm2. 
With bond coat BioK-1 4 N/
mm2, BioK-2 5 N/mm2,








HVSFS coating very dense and 
thin. Hardness 396–516 HV; 
elastic modulus 61–95 GPa. 






SPS Coatings compact and with 
continuous thickness with 
limited presence of pore
[42]
BG_Ca glass Ti6Al4V SPS Coatings continuous and 
homogeneous thickness 
31–40 μm; hardness 34–98 HV; 




45S5, Bio K Alumina Enameling 
technique
Bio K completely amorphous, 
45S5 some crystalline phases; 
both compact coatings. 








Substrate Technique Coatings’ characteristics Ref.
RKKP, AP40 Zirconia Enameling 
technique
Coatings with good mechanical 
properties and improved 
biocompatibility. ALP activity
1d 3.91 ± 1.15 μm AP40, 
4.69 ± 2.10 μm RKKP. 
9.98 ± 0.80 μm AP40 and 








Uniform and well distributed 
coatings. Thickness BG_Ca 
108 μm, BG_Ca/Mix 113 μm,
BG_Ca_K 121 μm; Vickers 











critical strain energy release 
6.56–14.61 J/m2
[47]
6P61, 6P55 Ti6Al4V Enameling 
technique















Sol–gel method Coatings without cracks 












Sol–gel method Glassy matrix with some defects 
and cracks. Thickness 1.5–3 _μm
[50]
45S5 BCG AZ31 
magnesium 
alloy
Sol–gel method Integrated coatings with some 
asperities. Thickness 1.1 μm
[51]
Ag-BG Titanium Sol–gel method Homogeneous and without 
macro and micro cracks
[52]
45S5 Ti6Al4V Electrophoretic 
deposition (EPD)
Coatings with good adhesion 
without cracks. Rough surface 
in which the initial powder 
particles are still visible.
Thickness 50–250 μm
[53]
Bioglass® NiTi Alloy EPD Homogeneous microstructure 








microcracks and pores. 
Thickness
1 μm; surface roughness 6 nm
[55]





Amorphous coatings with some 




Summary of bioactive glass coatings on different metallic substrate.
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investment programs in the field of nanotechnology is clear evidence of global 
interest in this field.
The potential evolutions of the research - development in the field of nano-
technologies, in the following years, are the following:
• half of the new materials that will appear will be obtained with the help of 
nanotechnologies, in sectors such as: electronics, chemical industry, heavy 
industry, pharmaceutical industry and aeronautical industry;
• the development of nanobiosystems science and engineering will allow a better 
understanding of living systems, the development of new solutions in health 
care and better biocompatible materials, the understanding of processes inside 
the cell or nervous system;
• application and integration of nanotechnology in fields of activity such as 
biology, electronics, medicine, etc., fields that include artificial organs, 
prolonging life, creating
• new systems by using biological principles, the laws of physics and the proper-
ties of different materials;
• tracking biocompatibility when creating new products;
• learning and education, based on nanoscale [22].
• In the future, the rapid development of nanomedicine could also be stimulated 
by better multidisciplinary collaboration between sectors of activity, such as 
industry, scientific research in general and medical research in particular.
7. Conclusions
In conclusion, bioglass is a chemical compound that belongs to a compositional 
family known to have the best bioactivity properties, as demonstrated by the con-
nection with living tissues in a short time to only a few hours.
It is also known that the generation of artificial bone tissue would be very useful 
in cases of massive fractures. Based on bioactive glass, three-dimensional bioactive 
matrices have also been developed for tissue regeneration using the deposition of 
human osteoblasts on the 3D matrix for tissue creation in vitro.
The results obtained so far qualify the bioglasses for widespread use in medical 
interventions and the ongoing research currently underway increases the hope of 
success of the intervention and also increases confidence in this material.
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